ASPIRE 2010 focuses on A.

Related StoriesEndocrine-disrupting chemical exposure linked to increased risk of diabetes and obesityCCRM Network companions with ACRM to provide outstanding patient care in the southeastern U.S.FEC recognizes Rachel S. Weinerman for receiving 2015 Scientific Plan Prize Paper AwardAs a complete result,Continue reading… ASPIRE 2010 focuses on A.

Affomix to generate antibodies against proprietary targets chosen by Kalgene Affomix Corporation.

Affomix to generate antibodies against proprietary targets chosen by Kalgene Affomix Corporation, a pioneer in the development of automated, high-throughput monoclonal antibody selection technology, announced today that Kalgene Pharmaceuticals Inc. Kalgene Pharmaceuticals Inc. Financial terms of the ongoing support agreementContinue reading… Affomix to generate antibodies against proprietary targets chosen by Kalgene Affomix Corporation.